Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas

Haematologica

Volumn 86, Issue 9, 2001, Pages 934-940

  Palacio, C ^a   Acebedo, G ^a   Navarrete, M ^a   Ruiz Marcellan C ^a   Sanchez, C ^a   Blanco, A ^a   Lopez A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Bone marrow; Diffuse large B cell lymphoma; Flow cytometry immunophenotyping; Follicular lymphoma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2;

ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

BONE MARROW; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL, FOLLICULAR; LYMPHOMA, NON-HODGKIN; SENSITIVITY AND SPECIFICITY;

EID: 0034791444     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project
2. Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients?
3. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'
4. Clinical stage 1 non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy
5. Alternating chemotherapy and radiotherapy for limited-stage intermediate and high- grade non-Hodgkin's lymphomas: Long-term results for 96 patients with tumor > 5 cm
6. High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: A dose-finding pilot study
7. Prognostic factors in aggressive malignant lymphomas: Description and validation of a prognostic index that could identify patients requiring a more intensive therapy
8. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
9. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project
10. Bone marrow staging in patients with non-Hodgkin's lymphoma: Is flow cytometry a useful test?
11. Immunophenotypic evaluation of the bone marrow in non-Hodgkin's lymphoma
12. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma
13. Bone marrow staging of patients with non-Hodgkin's lymphoma by flow cytometry: Correlation with morphology
14. Combined morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms
15. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
16. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization and validation of laboratory procedures
17. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations
18. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation
19. A simple salting out procedure for extracting DNA from human nucleated cells
20. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment
21. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation
22. Gene rearrangement in B and T lymphoproliferative disease detected by the polymerase chain reaction
23. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders
24. Clinical utility of flow cytometry in the chronic lymphoid leukemias
25. Proposals for the immunological classification of acute leukemias
26. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders
27. Morphologic, immunophenotypic, and molecular evaluation of bone marrow involvement in non-Hodgkin's Lymphoma
28. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma
29. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas
30. The pathologist's view point. Part II: Aggressive lymphomas
31. The pathologist's view point. Part I: Indolent lymphomas